KR20170007312A - 미생물 성장 매체 및 이를 이용하는 방법 - Google Patents
미생물 성장 매체 및 이를 이용하는 방법 Download PDFInfo
- Publication number
- KR20170007312A KR20170007312A KR1020167032666A KR20167032666A KR20170007312A KR 20170007312 A KR20170007312 A KR 20170007312A KR 1020167032666 A KR1020167032666 A KR 1020167032666A KR 20167032666 A KR20167032666 A KR 20167032666A KR 20170007312 A KR20170007312 A KR 20170007312A
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- phosphate buffer
- growth
- blood
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims description 96
- 239000001964 microbiological growth medium Substances 0.000 title 1
- 230000012010 growth Effects 0.000 claims abstract description 74
- 239000008363 phosphate buffer Substances 0.000 claims abstract description 65
- 239000012138 yeast extract Substances 0.000 claims abstract description 37
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 36
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 36
- 239000005018 casein Substances 0.000 claims abstract description 36
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 36
- 235000021240 caseins Nutrition 0.000 claims abstract description 36
- 239000008121 dextrose Substances 0.000 claims abstract description 36
- 244000005700 microbiome Species 0.000 claims abstract description 34
- 241001465754 Metazoa Species 0.000 claims abstract description 32
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 27
- 244000068988 Glycine max Species 0.000 claims abstract description 24
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims abstract description 24
- 229960003067 cystine Drugs 0.000 claims abstract description 24
- 239000004158 L-cystine Substances 0.000 claims abstract description 23
- 235000019393 L-cystine Nutrition 0.000 claims abstract description 23
- 229940025294 hemin Drugs 0.000 claims abstract description 22
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 claims abstract description 22
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 16
- 239000012528 membrane Substances 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims description 427
- 210000004369 blood Anatomy 0.000 claims description 105
- 239000008280 blood Substances 0.000 claims description 104
- 239000003349 gelling agent Substances 0.000 claims description 55
- 239000004094 surface-active agent Substances 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- 239000007788 liquid Substances 0.000 claims description 24
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 21
- 239000000499 gel Substances 0.000 claims description 20
- 239000008213 purified water Substances 0.000 claims description 18
- 229920001817 Agar Polymers 0.000 claims description 17
- 239000008272 agar Substances 0.000 claims description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- 230000003472 neutralizing effect Effects 0.000 claims description 17
- 230000001954 sterilising effect Effects 0.000 claims description 17
- 229920002148 Gellan gum Polymers 0.000 claims description 14
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 13
- 229920002907 Guar gum Polymers 0.000 claims description 13
- 239000000665 guar gum Substances 0.000 claims description 13
- 235000010417 guar gum Nutrition 0.000 claims description 13
- 229960002154 guar gum Drugs 0.000 claims description 13
- 235000010413 sodium alginate Nutrition 0.000 claims description 13
- 239000000661 sodium alginate Substances 0.000 claims description 13
- 229940005550 sodium alginate Drugs 0.000 claims description 13
- 239000007787 solid Substances 0.000 claims description 13
- 241000186216 Corynebacterium Species 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- 230000003139 buffering effect Effects 0.000 claims description 12
- 230000002949 hemolytic effect Effects 0.000 claims description 12
- 239000011734 sodium Substances 0.000 claims description 12
- 229910052708 sodium Inorganic materials 0.000 claims description 12
- 239000000230 xanthan gum Substances 0.000 claims description 12
- 229920001285 xanthan gum Polymers 0.000 claims description 12
- 235000010493 xanthan gum Nutrition 0.000 claims description 12
- 229940082509 xanthan gum Drugs 0.000 claims description 12
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 11
- 239000012736 aqueous medium Substances 0.000 claims description 11
- 241000589516 Pseudomonas Species 0.000 claims description 10
- 108010073771 Soybean Proteins Proteins 0.000 claims description 10
- 244000045947 parasite Species 0.000 claims description 10
- 229920002401 polyacrylamide Polymers 0.000 claims description 10
- 229940001941 soy protein Drugs 0.000 claims description 10
- 241000228212 Aspergillus Species 0.000 claims description 9
- 229920000136 polysorbate Polymers 0.000 claims description 9
- 229950008882 polysorbate Drugs 0.000 claims description 9
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 9
- 241000589291 Acinetobacter Species 0.000 claims description 8
- 241000588724 Escherichia coli Species 0.000 claims description 8
- 238000004090 dissolution Methods 0.000 claims description 8
- 108010010803 Gelatin Proteins 0.000 claims description 7
- 239000008273 gelatin Substances 0.000 claims description 7
- 229920000159 gelatin Polymers 0.000 claims description 7
- 229940014259 gelatin Drugs 0.000 claims description 7
- 235000019322 gelatine Nutrition 0.000 claims description 7
- 235000011852 gelatine desserts Nutrition 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 229920000936 Agarose Polymers 0.000 claims description 6
- 241000228143 Penicillium Species 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 4
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims description 4
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims description 4
- 239000000787 lecithin Substances 0.000 claims description 4
- 235000010445 lecithin Nutrition 0.000 claims description 4
- 229940067606 lecithin Drugs 0.000 claims description 4
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 claims description 4
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 4
- 229940068968 polysorbate 80 Drugs 0.000 claims description 4
- 229920000053 polysorbate 80 Polymers 0.000 claims description 4
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 claims description 4
- 241000589187 Rhizobium sp. Species 0.000 claims description 3
- 241000186429 Propionibacterium Species 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- 241000295644 Staphylococcaceae Species 0.000 claims 1
- 241001655322 Streptomycetales Species 0.000 claims 1
- 239000001963 growth medium Substances 0.000 abstract description 79
- 239000002609 medium Substances 0.000 abstract description 25
- 230000000813 microbial effect Effects 0.000 abstract description 11
- 210000001519 tissue Anatomy 0.000 description 37
- 108010076119 Caseins Proteins 0.000 description 32
- 102000011632 Caseins Human genes 0.000 description 32
- 210000004027 cell Anatomy 0.000 description 27
- 238000011084 recovery Methods 0.000 description 22
- 239000000523 sample Substances 0.000 description 21
- 238000012360 testing method Methods 0.000 description 21
- 241001494479 Pecora Species 0.000 description 20
- 229920001213 Polysorbate 20 Polymers 0.000 description 17
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 17
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 17
- 235000010633 broth Nutrition 0.000 description 15
- 229940068977 polysorbate 20 Drugs 0.000 description 15
- 239000008057 potassium phosphate buffer Substances 0.000 description 15
- 235000014469 Bacillus subtilis Nutrition 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 241000233866 Fungi Species 0.000 description 11
- 239000001974 tryptic soy broth Substances 0.000 description 11
- 108010050327 trypticase-soy broth Proteins 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 241000186427 Cutibacterium acnes Species 0.000 description 9
- 241000191940 Staphylococcus Species 0.000 description 9
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 241000191967 Staphylococcus aureus Species 0.000 description 7
- 241001148470 aerobic bacillus Species 0.000 description 7
- 238000004113 cell culture Methods 0.000 description 7
- 241001225321 Aspergillus fumigatus Species 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- 241000194017 Streptococcus Species 0.000 description 6
- 241000187747 Streptomyces Species 0.000 description 6
- 239000007330 chocolate agar Substances 0.000 description 6
- 235000011118 potassium hydroxide Nutrition 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 244000063299 Bacillus subtilis Species 0.000 description 5
- 206010018910 Haemolysis Diseases 0.000 description 5
- 241000589323 Methylobacterium Species 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000008588 hemolysis Effects 0.000 description 5
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 5
- 235000019796 monopotassium phosphate Nutrition 0.000 description 5
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000002689 soil Substances 0.000 description 5
- 239000008247 solid mixture Substances 0.000 description 5
- CWERGRDVMFNCDR-UHFFFAOYSA-M thioglycolate(1-) Chemical compound [O-]C(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-M 0.000 description 5
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 4
- 241000193403 Clostridium Species 0.000 description 4
- 241000579717 Dermacoccus Species 0.000 description 4
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 4
- 241000228150 Penicillium chrysogenum Species 0.000 description 4
- 241000191963 Staphylococcus epidermidis Species 0.000 description 4
- 239000003570 air Substances 0.000 description 4
- 229940091771 aspergillus fumigatus Drugs 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- -1 for example Substances 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000008055 phosphate buffer solution Substances 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000010802 sludge Substances 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- 241001430258 Methylobacterium radiotolerans Species 0.000 description 3
- 241000611786 Paenibacillus glucanolyticus Species 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 235000019764 Soybean Meal Nutrition 0.000 description 3
- 241000672916 Sphingomonas japonica Species 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 239000003708 ampul Substances 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 239000006161 blood agar Substances 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 150000004677 hydrates Chemical class 0.000 description 3
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229940055019 propionibacterium acne Drugs 0.000 description 3
- 229910001415 sodium ion Inorganic materials 0.000 description 3
- 239000004455 soybean meal Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- 241001331781 Aspergillus brasiliensis Species 0.000 description 2
- 241001328122 Bacillus clausii Species 0.000 description 2
- 241001661600 Bacillus idriensis Species 0.000 description 2
- 241000194108 Bacillus licheniformis Species 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- 241000194036 Lactococcus Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 241000589540 Pseudomonas fluorescens Species 0.000 description 2
- 244000088401 Pyrus pyrifolia Species 0.000 description 2
- 235000001630 Pyrus pyrifolia var culta Nutrition 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000736131 Sphingomonas Species 0.000 description 2
- 241000191984 Staphylococcus haemolyticus Species 0.000 description 2
- 241000192087 Staphylococcus hominis Species 0.000 description 2
- 240000007267 Stephania hernandifolia Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 210000000078 claw Anatomy 0.000 description 2
- 238000006114 decarboxylation reaction Methods 0.000 description 2
- 239000001177 diphosphate Substances 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- 235000019797 dipotassium phosphate Nutrition 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229940096118 ella Drugs 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 2
- 210000005000 reproductive tract Anatomy 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 229940071127 thioglycolate Drugs 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 description 2
- BDZKNNGXQCRJAZ-MMALYQPHSA-N (2r)-2-amino-3-[[(2r)-2-amino-2-carboxyethyl]disulfanyl]propanoic acid;sodium Chemical compound [Na].OC(=O)[C@@H](N)CSSC[C@H](N)C(O)=O BDZKNNGXQCRJAZ-MMALYQPHSA-N 0.000 description 1
- OQWBAXBVBGNSPW-MBJXGIAVSA-N (2s,3r,4s,5r,6r)-2-[(6-chloro-1h-indol-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC(Cl)=CC=C12 OQWBAXBVBGNSPW-MBJXGIAVSA-N 0.000 description 1
- PKDBCJSWQUOKDO-UHFFFAOYSA-M 2,3,5-triphenyltetrazolium chloride Chemical compound [Cl-].C1=CC=CC=C1C(N=[N+]1C=2C=CC=CC=2)=NN1C1=CC=CC=C1 PKDBCJSWQUOKDO-UHFFFAOYSA-M 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 244000303769 Amaranthus cruentus Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000193470 Clostridium sporogenes Species 0.000 description 1
- 241001518263 Corynebacterium tuberculostearicum Species 0.000 description 1
- 241000186245 Corynebacterium xerosis Species 0.000 description 1
- 241000191949 Dermacoccus nishinomiyaensis Species 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000306559 Exserohilum Species 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000579722 Kocuria Species 0.000 description 1
- 241001247311 Kocuria rhizophila Species 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 241000179039 Paenibacillus Species 0.000 description 1
- 241000123107 Phellinus Species 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241000190103 Setosphaeria rostrata Species 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 241001147736 Staphylococcus capitis Species 0.000 description 1
- 241000192086 Staphylococcus warneri Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 108010023197 Streptokinase Proteins 0.000 description 1
- 241000187216 Streptomyces halstedii Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000011213 bioburden testing Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012504 compendial method Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000035613 defoliation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000007773 growth pattern Effects 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 230000008642 heat stress Effects 0.000 description 1
- BTIJJDXEELBZFS-UHFFFAOYSA-K hemin Chemical compound [Cl-].[Fe+3].[N-]1C(C=C2C(=C(C)C(C=C3C(=C(C)C(=C4)[N-]3)C=C)=N2)C=C)=C(C)C(CCC(O)=O)=C1C=C1C(CCC(O)=O)=C(C)C4=N1 BTIJJDXEELBZFS-UHFFFAOYSA-K 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 244000052637 human pathogen Species 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 239000012569 microbial contaminant Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000007259 schaedler broth Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940037649 staphylococcus haemolyticus Drugs 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229960005202 streptokinase Drugs 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/045—Culture media therefor
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461983675P | 2014-04-24 | 2014-04-24 | |
| US61/983,675 | 2014-04-24 | ||
| PCT/US2015/027652 WO2015164827A1 (en) | 2014-04-24 | 2015-04-24 | Microbiological growth media and methods of using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20170007312A true KR20170007312A (ko) | 2017-01-18 |
Family
ID=54333323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020167032666A Ceased KR20170007312A (ko) | 2014-04-24 | 2015-04-24 | 미생물 성장 매체 및 이를 이용하는 방법 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US10793823B2 (enExample) |
| EP (1) | EP3134511A4 (enExample) |
| JP (3) | JP7084719B2 (enExample) |
| KR (1) | KR20170007312A (enExample) |
| CN (1) | CN106459892A (enExample) |
| AU (3) | AU2015249274B2 (enExample) |
| BR (1) | BR112016024635A2 (enExample) |
| CA (1) | CA2946758C (enExample) |
| HK (1) | HK1232252A1 (enExample) |
| MX (2) | MX383963B (enExample) |
| SG (2) | SG11201608859PA (enExample) |
| WO (1) | WO2015164827A1 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102165688B1 (ko) | 2020-04-03 | 2020-10-14 | 주식회사 퀀타매트릭스 | 그람 양성균 배양용 배양액 |
| KR102334454B1 (ko) | 2020-05-29 | 2021-12-03 | 코스맥스 주식회사 | 코리네박테리움 투베르쿨로스테아리쿰 균주 및 그의 피부 상태 개선 용도 |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112016024635A2 (pt) | 2014-04-24 | 2017-08-15 | Rapid Micro Biosystems Inc | meios de crescimento microbiológico e métodos de uso do mesmo |
| CN109019867A (zh) * | 2018-05-20 | 2018-12-18 | 安信达环保科技（宁波）有限公司 | 一种氨氮去除菌缓释剂、及其制备方法和应用 |
| US20230131415A1 (en) | 2020-04-15 | 2023-04-27 | Rapid Micro Biosystems, Inc. | Attenuated-background microbiological nutrient media and methods of using the same |
| CN113430246B (zh) * | 2021-06-10 | 2023-06-20 | 佛山市海天(宿迁)调味食品有限公司 | 一种用于蚝油灌装空间的空气微生物快速检测方法 |
| CN113736717B (zh) * | 2021-11-03 | 2022-02-11 | 广东省科学院生态环境与土壤研究所 | 一株具有脱氮功能和缺氧抗逆性的甲烷氧化菌及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5891709A (en) * | 1992-07-13 | 1999-04-06 | The United States Of America As Represented By The Secretary Of The Agriculture | Campy-Cefex selective and differential medium for campylobacter |
| WO2003045459A1 (en) * | 2001-11-30 | 2003-06-05 | UNIVERSITé LAVAL | Milk protein biofilm and uses thereof |
| JP2004208640A (ja) | 2003-01-07 | 2004-07-29 | Rengo Co Ltd | 無細胞系タンパク質合成用酵母抽出液およびその調製方法、ならびにそれを用いた無細胞系タンパク質合成方法 |
| WO2005028626A2 (en) * | 2003-09-18 | 2005-03-31 | Raven Biotechnologies, Inc. | Cell culture media |
| WO2005064016A1 (ja) | 2003-12-26 | 2005-07-14 | Prima Meat Packers, Ltd. | 微生物の多重検出方法 |
| US8257964B2 (en) | 2006-01-04 | 2012-09-04 | Cell ASIC | Microwell cell-culture device and fabrication method |
| CA2623408C (en) | 2005-09-26 | 2014-04-01 | Rapid Micro Biosystems, Inc. | Cassette containing growth medium |
| US8066986B2 (en) | 2007-02-01 | 2011-11-29 | Master Supplements, Inc. | Formulations including digestive enzymes and polysorbate surfactants that enhance the colonization of administered probiotics microoganisms |
| PT2427567E (pt) | 2009-05-04 | 2015-06-25 | Novartis Ag | Microensaio rápido de esterilidade |
| JP2011001352A (ja) | 2009-05-19 | 2011-01-06 | Adeka Clean Aid Co Ltd | ナイシンの殺菌上有効な使用方法 |
| EP2585189A2 (en) | 2010-06-23 | 2013-05-01 | Stobbe Tech A/s | Biopharmaceutical process apparatuses assembled into a column |
| JP2012217440A (ja) | 2011-04-14 | 2012-11-12 | Nissui Pharm Co Ltd | 袋状微生物検出用容器 |
| WO2013070730A2 (en) | 2011-11-07 | 2013-05-16 | Rapid Micro Biosystems, Inc. | Cassette for sterility testing |
| CN107345204B (zh) | 2011-12-03 | 2021-02-12 | Emd密理博公司 | 用于微流体细胞培养的微型培育系统和方法 |
| MX375939B (es) | 2012-04-16 | 2025-03-07 | Rapid Micro Biosystems Inc | Dispositivo para cultivar celulas. |
| US9238789B2 (en) | 2012-07-21 | 2016-01-19 | Therapeutic Proteins International, LLC | Baffled single use bioreactor |
| FR2997091B1 (fr) | 2012-10-22 | 2016-05-06 | Fond Mediterranee Infection | Utilisation d'un compose antioxydant pour la culture de bacteries sensibles a la tension en oxygene |
| BR112016024635A2 (pt) | 2014-04-24 | 2017-08-15 | Rapid Micro Biosystems Inc | meios de crescimento microbiológico e métodos de uso do mesmo |
-
2015
- 2015-04-24 BR BR112016024635A patent/BR112016024635A2/pt not_active Application Discontinuation
- 2015-04-24 WO PCT/US2015/027652 patent/WO2015164827A1/en not_active Ceased
- 2015-04-24 CA CA2946758A patent/CA2946758C/en active Active
- 2015-04-24 JP JP2017507933A patent/JP7084719B2/ja active Active
- 2015-04-24 MX MX2016013995A patent/MX383963B/es unknown
- 2015-04-24 CN CN201580034049.1A patent/CN106459892A/zh active Pending
- 2015-04-24 US US15/305,789 patent/US10793823B2/en active Active
- 2015-04-24 HK HK17105764.4A patent/HK1232252A1/zh unknown
- 2015-04-24 SG SG11201608859PA patent/SG11201608859PA/en unknown
- 2015-04-24 EP EP15782801.3A patent/EP3134511A4/en active Pending
- 2015-04-24 SG SG10201809259SA patent/SG10201809259SA/en unknown
- 2015-04-24 KR KR1020167032666A patent/KR20170007312A/ko not_active Ceased
- 2015-04-24 AU AU2015249274A patent/AU2015249274B2/en active Active
-
2016
- 2016-10-24 MX MX2020011318A patent/MX2020011318A/es unknown
-
2020
- 2020-10-05 US US17/063,108 patent/US11732237B2/en active Active
-
2021
- 2021-07-02 JP JP2021110510A patent/JP2021168668A/ja active Pending
- 2021-10-22 AU AU2021254655A patent/AU2021254655B2/en active Active
-
2023
- 2023-06-13 US US18/333,957 patent/US12359161B2/en active Active
-
2024
- 2024-03-14 AU AU2024201706A patent/AU2024201706A1/en active Pending
- 2024-06-11 JP JP2024094078A patent/JP2024116294A/ja active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102165688B1 (ko) | 2020-04-03 | 2020-10-14 | 주식회사 퀀타매트릭스 | 그람 양성균 배양용 배양액 |
| KR102334454B1 (ko) | 2020-05-29 | 2021-12-03 | 코스맥스 주식회사 | 코리네박테리움 투베르쿨로스테아리쿰 균주 및 그의 피부 상태 개선 용도 |
Also Published As
| Publication number | Publication date |
|---|---|
| HK1232252A1 (zh) | 2018-01-05 |
| US10793823B2 (en) | 2020-10-06 |
| US20210269764A1 (en) | 2021-09-02 |
| SG10201809259SA (en) | 2018-11-29 |
| WO2015164827A1 (en) | 2015-10-29 |
| US11732237B2 (en) | 2023-08-22 |
| JP7084719B2 (ja) | 2022-06-15 |
| AU2015249274A1 (en) | 2016-12-08 |
| CA2946758C (en) | 2022-08-30 |
| JP2024116294A (ja) | 2024-08-27 |
| BR112016024635A2 (pt) | 2017-08-15 |
| AU2015249274B2 (en) | 2021-07-22 |
| AU2021254655A1 (en) | 2021-11-18 |
| EP3134511A4 (en) | 2017-12-06 |
| US20230323283A1 (en) | 2023-10-12 |
| AU2021254655B2 (en) | 2023-12-14 |
| SG11201608859PA (en) | 2016-11-29 |
| JP2021168668A (ja) | 2021-10-28 |
| US12359161B2 (en) | 2025-07-15 |
| CA2946758A1 (en) | 2015-10-29 |
| EP3134511A1 (en) | 2017-03-01 |
| JP2017513532A (ja) | 2017-06-01 |
| CN106459892A (zh) | 2017-02-22 |
| MX2020011318A (es) | 2020-12-07 |
| US20170044486A1 (en) | 2017-02-16 |
| MX383963B (es) | 2025-03-14 |
| MX2016013995A (es) | 2017-08-22 |
| AU2024201706A1 (en) | 2024-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12359161B2 (en) | Microbiological growth media and methods of using the same | |
| Chandrasekar et al. | Clinical issues of blood cultures | |
| Ehrenkranz et al. | Antibiotic-sensitive Serratia marcescens infections complicating cardiopulmonary operations: contaminated disinfectant as a reservoir | |
| Ananthanarayan | Ananthanarayan and Paniker's textbook of microbiology | |
| Fairbrother et al. | A Text-book of Bacteriology | |
| CN108300756A (zh) | 硝呋太尔胶囊的微生物限度检查方法 | |
| Muralidhar | Lippincott Illustrated Reviews Microbiology | |
| RU2841400C1 (ru) | Способ получения питательной среды жидкой обогащенной для культивирования лептоспир | |
| CN113699085B (zh) | 拮抗菌ed5及其应用 | |
| Denyer et al. | Introduction to pharmaceutical microbiology | |
| RU2790481C1 (ru) | Антибактериальная композиция на основе эндолизинов и лекарственные средства в форме геля или спрея с ее использованием | |
| Mousa Alobaidy et al. | Comparison between the Effect of Secondary Metabolic Products of Nutrient Medium and Modified Medium of Yeast Saccharomyces boulardii Against Different Bacterial Species. | |
| Iduh et al. | Antimicrobial Activities of Sokoto Prepared Black Soap (Sabulun Salo) on Clinical Isolates of Candida albicans, Staphylococcus aureus and Escherichia coli. | |
| CN106939329B (zh) | 一种用于检测霉菌性阴道炎的培养液、试剂盒及检测方法 | |
| Tyagi et al. | A study to check the status of enterotoxin production by Staphylococcus aureus in milk and milk products. | |
| Rogachev et al. | METHODS OF STUDYG STAPHYLOCOCCAL INFECTION | |
| Puşcaş | A new procedure for the rapid determination of pseudomonas aeruginosa bacteria in medications | |
| Pușcaș | A new procedure for the rapid determination of Pseudomonas aeruginosa bacteria in medications | |
| Mohaisen | The By-product Metabolic Effect of Saccharomyces Ellipsoideus against Some Medically Important Bacterial Species from Conventional and Modified Growth Media | |
| CN106755279A (zh) | 用于检测细菌性阴道炎的培养液、试剂盒及检测方法 | |
| Mahmood | Hashim Yousif Yassin | |
| CZ33338U1 (cs) | Kultivační půda pro odlišení Staphylococcus epidermidis od jiných druhů rodu Staphylococcus | |
| CHANG | School of Engineering and School of Public Health, Harvard University, Boston, Mass. The prevalence of amoebic dysentery and liver abscess among the | |
| Haberer et al. | Microbiological Methods of the Pharmacopoeia | |
| Al-Waeely et al. | Characterization of virulence factors of Staphylococus saprophyticus isolated from women with cystitis. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20161123 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20200417 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20210831 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20220303 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20210831 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |